Ignite Creation Date:
2025-12-25 @ 12:41 AM
Ignite Modification Date:
2025-12-25 @ 10:52 PM
Study NCT ID:
NCT00587067
Status:
COMPLETED
Last Update Posted:
2023-04-04
First Post:
2007-12-21
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Phase II Study of Continuous Hepatic Arterial Infusion With Floxuridine (FUDR) and Dexamethasone (DEX) in Patients With Unresectable Primary Hepatic Malignancy
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-06
Start Date Type:
None
Primary Completion Date:
2016-05-19
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-05-19
Completion Date Type:
ACTUAL
First Submit Date:
2007-12-21
First Submit QC Date:
None
Study First Post Date:
2008-01-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-05-09
Results First Submit QC Date:
None
Results First Post Date:
2017-08-04
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-03-31
Last Update Post Date:
2023-04-04
Last Update Post Date Type:
ACTUAL